Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience

BackgroundCinacalcet is a calcimimetic approved in adults with primary hyperparathyroidism (PHPT). Few cases reports described its use in pediatric HPT, with challenges related to the risk of hypocalcemia, increased QT interval and drug interactions. In this study, we report the French experience in...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Julie Bernardor, Sacha Flammier, Jean-Pierre Salles, Cyril Amouroux, Mireille Castanet, Anne Lienhardt, Laetitia Martinerie, Ivan Damgov, Agnès Linglart, Justine Bacchetta
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2022-08-01
סדרה:	Frontiers in Pediatrics
נושאים:	children primary hyperparathyroidism cinacalcet hypercalcemia Calcium-sensing Receptor (CaSR)
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fped.2022.926986/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!